Valuation Ultimovacs ASA OTC Markets

Stocks

ULTMF

NO0010851603

Delayed OTC Markets 20:10:00 2024-01-24 EST 5-day change 1st Jan Change
13.33 USD -.--% Intraday chart for Ultimovacs ASA -.--% -

Company Valuation: Ultimovacs ASA

Data adjusted to current consolidation scope
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Market Cap 1 109.2 255.8 386 378.4 422.5 8.017
Change - 134.21% 50.91% -1.98% 11.67% -98.1%
Enterprise Value (EV) 1 -286.8 -181.4 -186.1 -41.47 159.7 -97.26
Change - 36.76% -2.6% 77.71% 485.02% -160.92%
P/E -1.47x -2.01x -2.22x -2.25x -2.23x -0.04x
PBR 0.25x 0.52x 0.65x 0.84x 1.51x 0.1x
PEG - -0x -0.1x 0.61x -0.2x -0.01x
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA 4.37x 1.53x 1.14x 0.23x -0.74x 0.65x
EV / EBIT 4.33x 1.52x 1.14x 0.23x -0.74x 0.64x
EV / FCF 7.25x 2.83x 2.88x 0.43x -1.55x 0.86x
FCF Yield 13.8% 35.3% 34.7% 233% -64.6% 116%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -26.68 -39.84 -50.88 -48.99 -55.01 -58.44
Distribution rate - - - - - -
Net sales - - - - - -
EBITDA 1 -65.58 -118.2 -162.8 -178.2 -214.8 -150.4
EBIT 1 -66.22 -119.1 -163.8 -179.1 -215.7 -151.3
Net income 1 -61.17 -120.6 -164.7 -167.8 -189.2 -201.1
Net Debt 1 -396 -437.1 -572.1 -419.8 -262.8 -105.3
Reference price 2 39.200 80.000 112.800 110.000 122.800 2.330
Nbr of stocks (in thousands) 2,786 3,197 3,422 3,440 3,441 3,441
Announcement Date 4/1/20 3/25/21 3/25/22 3/24/23 3/21/24 4/4/25
1NOK in Million2NOK
Estimates

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!